Meeder Advisory Services’s Bristol-Myers Squibb BMY Stock Holding History

Meeder Advisory Services's BMY Position: Q2 2026 in Review

Meeder Advisory Services reduced its Bristol-Myers Squibb (BMY) stake by 2.8% in Q2 2026, selling an estimated $48.8K and leaving 29,270 shares worth $1.69M. The position accounts for 0.06% of the portfolio, ranked #215.

Meeder Advisory Services first reported a position in BMY in Q4 2022 and has held it in 15 quarters since. The position peaked at $2.24M in Q1 2025. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

• Meeder Advisory Services held 29,270 shares of Bristol-Myers Squibb worth $1.69M as of Q2 2026.
• Meeder Advisory Services sold 849 Bristol-Myers Squibb shares in Q2 2026, an estimated $48.8K.
• Bristol-Myers Squibb made up 0.06% of Meeder Advisory Services's portfolio in Q2 2026, its #215 holding.
• Meeder Advisory Services first reported a position in Bristol-Myers Squibb in Q4 2022 and has held it in 15 quarters since.
• Meeder Advisory Services's Bristol-Myers Squibb position peaked at $2.24M in Q1 2025.
• 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Meeder Advisory Services's 13F filing for Q2 2026, filed 7 Aug 2026.